首页> 外文期刊>Journal of Controlled Release: Official Journal of the Controlled Release Society >Effectiveness of tissue engineered chitosan-gelatin composite scaffold loaded with human platelet gel in regeneration of critical sized radial bone defect in rat
【24h】

Effectiveness of tissue engineered chitosan-gelatin composite scaffold loaded with human platelet gel in regeneration of critical sized radial bone defect in rat

机译:组织工程壳聚糖 - 明胶复合支架在大鼠临界大小桡骨缺损中载有人血小板凝胶的含量

获取原文
获取原文并翻译 | 示例
           

摘要

Although many strategies have been utilized to accelerate bone regeneration, an appropriate treatment strategy to regenerate a new bone with optimum morphology and mechanical properties has not been invented as yet. This study investigated the healing potential of a composite scaffold consisting of chitosan (CS), gelatin (Gel) and platelet gel (PG), named CS-Gel-PG, on a bilateral critical sized radial bone defect in rat. Eighty radial bone defects were bilaterally created in 40 Sprague-Dawley rats and were randomly divided into eight groups including untreated, autograft, CS, Gel, CS-PG, Gel-PG, CS-Gel, and CS-Gel-PG treated defects. The bone defects were evaluated clinically and radiologically during the study and their bone samples were assessed by gross and histopathology, histomorphometry, CT-scan, scanning electron microscopy, and biomechanical testing after 8 weeks of bone injury. The autograft and CS-Gel-PG groups showed significantly higher new bone formation, density of osseous and cartilaginous tissues, bone volume, and mechanical performance than the defect, CS and Gel-PG groups (P. 0.05). In addition, bone volume, density of osseous and cartilaginous tissues, and numbers of osteons in the CS-Gel-PG group were significantly superior to the CS-PG, CS-Gel and Gel groups (P. 0.05). Increased mRNA levels of alkaline phosphatase, runt-related transcription factor 2, osteocalcin, collagen type 1 and CD31, vascular endothelial growth factor as osteogenic and angiogenic differentiation markers were found with the CS-Gel-PG scaffold by quantitative real-time PCR in vitro after 30 days of culturing on bone marrowderived mesenchymal stem cells. In conclusion, the healing potential of CS-Gel scaffold embedded with PG was comparable to autografting and therefore, it can be offered as an appropriate scaffold in bone tissue engineering and regenerative applications.
机译:虽然已经利用了许多策略来加速骨再生,但是尚未发明,以获得具有最佳形态和机械性能的适当治疗策略来再生新骨骼和机械性能。该研究研究了由壳聚糖(Cs),明胶(凝胶)和血小板凝胶(PG)组成的复合支架的愈合电位在大鼠的双侧临界大小的径向骨缺损上。在40只Sprague-Dawley大鼠中双侧产生了八十径向骨缺损,随机分为八组,包括未处理,自体移植,Cs,凝胶,CS-PG,凝胶PG,CS-凝胶和CS-GEL-PG处理的缺陷。在研究期间临床和放射学评估骨缺陷,并且通过总体和组织病理学,组织术,CT扫描,扫描电子显微镜和8周后的生物力学测试评估它们的骨样品。自体移植和Cs-GEL-PG基团显示出明显较高的新骨形成,骨质和软骨组织,骨骼体积和机械性能而不是缺陷,Cs和凝胶 - Pg组(第0.05页)。另外,CS-GEL-PG组中的骨体积,骨质和软骨组织和CS-GEL-PG组中的骨数显着优于CS-PG,CS-凝胶和凝胶基团(P.0.05)。通过定量实时PCR在体外用CS-GEL-PG支架发现碱性磷酸酶,runt相关转录因子2,骨钙蛋白,胶原蛋白,1型和CD31,血管内皮生长因子,血管内皮生长因子的增加,血管内皮生长因子的增加30天后培养骨髓性间充质干细胞。总之,嵌入PG的CS-GEL支架的愈合电位与自身生物相当,因此可以在骨组织工程和再生应用中作为合适的支架提供。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号